Viewing Study NCT02120404

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-05-26 @ 12:10 AM
Study NCT ID: NCT02120404
Status: UNKNOWN
Last Update Posted: 2023-08-31
First Post: 2014-04-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Septic Shock View
Keywords:

Keywords

Keyword Brief Keyword Text View
None septic shock, hemodynamic tolerance, esmolol View